TNFSF13B and inflammatory bowel disease: Previously, we detected increased expression of BAFF in serum and colon in IBD patients, with sensitivity, specificity and AUC of 88%, 100% and 0.936 in UC patients compared to irritable bowel syndrome (IBS) patients or healthy controls, respectively (8).